EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention

Bandana Kumari, Rijhul Lahariya

GMS German Medical Science · 01.10.2025 · 23 (Doc11) · Doc11

DOI: 10.3205/000347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GMS German Medical Science, erschienen am 01.10.2025. Verfasst von Bandana Kumari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, Patna, Bihar, India. Hauptthemen laut MEDLINE: Insulin Resistance, Breast Neoplasms, Triglycerides, Blood Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Breast cancer is the most commonly diagnosed malignancy worldwide. Insulin resistance (IR) plays a key role in its progression by activating oncogenic signaling pathways. The triglyceride-glucose (TyG) index is a validated, cost-effective surrogate marker for IR. This study aims to evaluate the prevalence of IR in female breast cancer patients using the TyG index and to identify lipid parameters associated with increased IR, thereby supporting strategies for secondary prevention.

Methods

A cross-sectional study was conducted among non-diabetic, histopathologically confirmed female breast cancer patients. Demographic data, lipid profiles, and fasting glucose levels were collected. Participants were stratified into high-risk (TyG≥8.87) and low-risk (TyG

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceBreast NeoplasmsTriglyceridesBlood GlucoseHumansFemaleMiddle AgedCross-Sectional StudiesAdultSecondary PreventionAgedBiomarkersRisk Factors

Stichwörter der Autor:innen

breast neoplasminsulin resistancelipid profilelogistic regressiontriglycerides

Substanzen

TriglyceridesBlood GlucoseBiomarkers

Autor:innen und Institutionen

  • Department of Biochemistry, All India Institute of Medical Sciences, Patna, Bihar, India.
  • All India Institute of Medical Sciences, Patna, Bihar, India.

Zitieren

APA

Kumari, B., & Lahariya, R. (2025). Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention. GMS German Medical Science, 23(Doc11), Doc11. https://doi.org/10.3205/000347

Vancouver

Kumari B, Lahariya R. Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention. GMS German Medical Science. 2025;23(Doc11):Doc11. doi:10.3205/000347

BibTeX
@article{Kumari2025,
  author = {Kumari, Bandana and Lahariya, Rijhul},
  title = {Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention},
  journal = {GMS German Medical Science},
  year = {2025},
  volume = {23},
  number = {Doc11},
  pages = {Doc11},
  doi = {10.3205/000347}
}
Kostenlos starten →